These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 1529762)

  • 1. NPY-(18-36) and pertussis toxin distinguish between the negative and positive contractile effects of neuropeptide Y (NPY) in ventricular cardiomyocytes.
    Millar BC; McDermott BJ; Piper HM; Balasubramaniam A; Weis T
    Adv Exp Med Biol; 1992; 311():325-6. PubMed ID: 1529762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positive and negative contractile effects of neuropeptide Y on ventricular cardiomyocytes.
    Millar BC; Weis T; Piper HM; Weber M; Borchard U; McDermott BJ; Balasubramaniam A
    Am J Physiol; 1991 Dec; 261(6 Pt 2):H1727-33. PubMed ID: 1661086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The negative inotropic effect of neuropeptide Y on the ventricular cardiomyocyte.
    Piper HM; Millar BC; McDermott BJ
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Sep; 340(3):333-7. PubMed ID: 2554154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of D-myo inositol 1,2,6 trisphosphate to inhibit contractile activity in rat ventricular cardiomyocytes induced by neuropeptide Y and other cardioactive peptides through phospholipase C.
    Bell D; Millar BC; McDermott BJ
    Br J Pharmacol; 1997 Dec; 122(8):1655-60. PubMed ID: 9422811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of neuropeptide Y on cell length and membrane currents in isolated guinea pig ventricular myocytes.
    Bryant SM; Ryder KO; Hart G
    Circ Res; 1991 Oct; 69(4):1106-13. PubMed ID: 1934339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropeptide Y Y2 receptor-mediated attenuation of neurogenic plasma extravasation acting through pertussis toxin-sensitive mechanisms.
    Yu XJ; Moskowitz MA
    Br J Pharmacol; 1996 Sep; 119(2):229-32. PubMed ID: 8886402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of positive charges of neuropeptide Y fragments in mast cell activation.
    Mousli M; Landry Y
    Agents Actions; 1994 Jun; 41 Spec No():C41-2. PubMed ID: 7526655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropeptide Y (18-36) modulates chromaffin cell catecholamine secretion by blocking the nicotinic receptor ion channel.
    Zheng J; Morrisett RA; Zhu J; Hexum TD
    J Pharmacol Exp Ther; 1995 Aug; 274(2):891-7. PubMed ID: 7543575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pertussis toxin abolishes the effect of neuropeptide Y on rat resistance arteriole contraction.
    Andriantsitohaina R; Andre P; Stoclet JC
    Am J Physiol; 1990 Nov; 259(5 Pt 2):H1427-32. PubMed ID: 1700631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracerebroventricularly administered pertussis toxin blocks the central vasopressor action of neuropeptide Y(13-36) in the awake unrestrained male rat.
    Narváez JA; Aguirre JA; Van der Ploeg I; Fuxe K
    Neurosci Lett; 1992 Jun; 140(2):273-6. PubMed ID: 1386917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracellular signaling leads to the hypertrophic effect of neuropeptide Y.
    Goldberg Y; Taimor G; Piper HM; Schlüter KD
    Am J Physiol; 1998 Nov; 275(5):C1207-15. PubMed ID: 9814968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropeptide Y stimulates luteinizing hormone-releasing hormone release from superfused hypothalamic GT1-7 cells.
    Besecke LM; Wolfe AM; Pierce ME; Takahashi JS; Levine JE
    Endocrinology; 1994 Oct; 135(4):1621-7. PubMed ID: 7925125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropeptide Y enhances ATP-induced formation of inositol phosphates in chromaffin cells.
    Zheng J; Zhang P; Toews M; Hexum TD
    Biochem Biophys Res Commun; 1997 Oct; 239(1):287-90. PubMed ID: 9345312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropeptide Y increases 4-aminopyridine-sensitive transient outward potassium current in rat ventricular myocytes.
    Heredia MP; Fernández-Velasco M; Benito G; Delgado C
    Br J Pharmacol; 2002 Apr; 135(7):1701-6. PubMed ID: 11934810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropeptide Y inhibits renin release by a pertussis toxin-sensitive mechanism.
    Hackenthal E; Aktories K; Jakobs KH; Lang RE
    Am J Physiol; 1987 Mar; 252(3 Pt 2):F543-50. PubMed ID: 3548437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropeptide Y stimulates DNA synthesis in vascular smooth muscle cells.
    Shigeri Y; Fujimoto M
    Neurosci Lett; 1993 Jan; 149(1):19-22. PubMed ID: 8469373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropeptide Y inhibits forskolin-stimulated adenylate cyclase in bovine adrenal chromaffin cells via a pertussis toxin-sensitive process.
    Zhu J; Li W; Toews ML; Hexum TD
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1479-86. PubMed ID: 1335068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pertussis toxin attenuates postsynaptic actions of neuropeptide Y on the guinea-pig uterine artery.
    Morris JL
    Eur J Pharmacol; 1991 Oct; 203(2):275-81. PubMed ID: 1800121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropeptide Y-induced intracellular Ca2+ increases in vascular smooth muscle cells.
    Mihara S; Shigeri Y; Fujimoto M
    FEBS Lett; 1989 Dec; 259(1):79-82. PubMed ID: 2480920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presynaptic inhibition by neuropeptide Y and baclofen in hippocampus: insensitivity to pertussis toxin treatment.
    Colmers WF; Pittman QJ
    Brain Res; 1989 Sep; 498(1):99-104. PubMed ID: 2507090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.